Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data (Q33287677)

25 July 2017

title

Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data (English)

1 reference

25 July 2017

Petr Kozler

7

0 references

Filip Kramář

object named as

Filip Kramar

1

0 references

Zuzana Zemanová

object named as

Zuzana Zemanova

2

0 references

Kyra Michalová

object named as

Kyra Michalova

3

0 references

author name string

Libuse Babicka

4

1 reference

25 July 2017

Sarka Ransdorfova

5

1 reference

25 July 2017

Petr Hrabal

6

1 reference

25 July 2017

publication date

14 June 2007

1 reference

Journal of Neuro-Oncology

25 July 2017

published in

1 reference

25 July 2017

volume

84

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

201-211

1 reference

Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.

25 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9358-7

Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival

21 January 2018

1 reference

12 December 2020

Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions

1 reference

12 December 2020

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

1 reference

12 December 2020

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

1 reference

12 December 2020

p14ARF links the tumour suppressors RB and p53.

1 reference

12 December 2020

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

1 reference

12 December 2020

Anaplastic oligodendroglial tumors: a tale of two trials.

1 reference

12 December 2020

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma

1 reference

12 December 2020

Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

1 reference

12 December 2020

Relationship between gene amplification and chromosomal deviations in malignant human gliomas

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

1 reference

12 December 2020

Epidemiology of primary brain tumors: current concepts and review of the literature

1 reference

12 December 2020

Glioma invasion in the central nervous system

1 reference

12 December 2020

Absence of mutation of the p73 gene in astrocytic neoplasms.

1 reference

12 December 2020

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

1 reference

12 December 2020

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

12 December 2020

Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.

1 reference

12 December 2020

p14ARF deletion and methylation in genetic pathways to glioblastomas.

1 reference

12 December 2020

Growth factors, glia and gliomas

1 reference

12 December 2020

Descriptive epidemiology of cerebral gliomas in France.

1 reference

12 December 2020

p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.

1 reference

12 December 2020

Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.

1 reference

12 December 2020

Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.

1 reference

12 December 2020

Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.

1 reference

12 December 2020

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

12 December 2020

High frequency of CDKN2A alterations in esophageal squamous cell carcinoma from a high-risk Chinese population

1 reference

12 December 2020

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

1 reference

12 December 2020

Alterations of the TP53 gene in human gliomas

1 reference

12 December 2020

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

1 reference

12 December 2020

EGF receptor amplification and expression in human brain tumours

1 reference

12 December 2020

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

12 December 2020

Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.

1 reference

12 December 2020

Molecular cytogenetic stratification of recurrent oligodendrogliomas: utility of interphase fluorescence in situ hybridization (I-FISH).

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

1 reference

12 December 2020

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification

1 reference

12 December 2020

A transcript map of the chromosome 19q-arm glioma tumor suppressor region

1 reference

12 December 2020

Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.

1 reference

12 December 2020

Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.

1 reference

12 December 2020

Deletion of p16 and p15 genes in brain tumors

1 reference

12 December 2020

PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas

1 reference

12 December 2020

Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p.

1 reference

12 December 2020

10.1007/S11060-007-9358-7

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1017881293

0 references

1 reference